Project Details
Description
Osteoporosis, the reduction of bone mineral density and deterioration of bone microarchitecture, is a bone disease that leads to an increased risk of fracture. Therapeutic strategy however has not been established for ameliorating osteoporosis. Increasing research on microRNAs (miRNAs) has unraveled their important role in pathophysiology. Recent in vitro evidence indicate that miRNA-204 regulates Runx2 protein expression, a key transcription factor for osteogenesis. However, there is lacking of well-designed bone formation model for in vivo verification. This study aims to unravel the involvement of miRNAs-204 mediated Runx2 protein in regulating osteogenesis in vivo, using the Japanese medaka (Oryzias latipes) which has been shown useful for studying miRNA regulation of organ development in vivo. The molecular mechanisms regulating metabolism of bone forming cell (osteoblast) and bone resorbing cell (osteoclast) have been well established for medaka, which are highly conservative in vertebrates. Our recent findings revealed similar progression of osteoporosis in ageing medaka. Given the transparent nature during early development, the medaka offers additional advantage for studying miRNA-204 mediated Runx2 regulation of osteogenesis in vivo. The findings derived from this unique medaka model are significant for future development of novel strategy for remodeling osteoporosis.
| Project number | 7003024 |
|---|---|
| Grant type | SG |
| Status | Finished |
| Effective start/end date | 1/04/13 → 16/06/14 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.